Cardinal Health Beats Fiscal Q1 2027 Estimates as Revenue Rises 5.5% to $67.51B

Cardinal Health (CAH) beat estimates for the fiscal first quarter of 2027 on both revenue and adjusted EPS. Revenue was $67.51 billion, up 5.5% from a year earlier, above the $66.67 billion estimate, and adjusted EPS was $3.26, up 28% from a year earlier, above the $2.94 estimate.

Shares rose 2.7% in premarket trading as of 6:32 a.m. ET, to $268.99 from a $261.93 close.

Fiscal Q1 2027 scorecard

By our calculation, revenue was $844.0 million above the estimate and adjusted EPS was $0.32 above it. The QoQ column compares with the previous quarter's revenue of $63.67 billion and adjusted EPS of $2.91. The YoY column compares with $64.01 billion and $2.55 in the same quarter a year earlier.

Track record

• EPS record. Adjusted EPS beat the estimate in 8 of the last 8 reports, including this one.
• Revenue record. Revenue beat the estimate in 4 of the last 8 reports.
• Revenue trend. Revenue over the last 5 reports, oldest first: $64.01 billion, $65.63 billion, $60.94 billion, $63.67 billion and $67.51 billion.

What to watch

• Next-quarter estimates. Consensus calls for EPS of $3.12 and revenue of $68.30 billion next quarter, based on 9 analysts.
• Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 5.5% increase to $67.51 billion.
• Estimate record. Whether Cardinal Health extends a record of beating EPS estimates in 8 of its last 8 reports.
• Related coverage. See our reports on Zai Lab, BeOne Medicines, NewAmsterdam Pharma and Advanced Drainage Systems.

Sources: Results are from Cardinal Health's Nov. 5, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Cardinal Health's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.